https://stock.noler.com/us/stock/zyme https://stock.noler.com/us/stock/zyme/13f-holdings https://stock.noler.com/us/stock/zyme/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/zyme/accounts-payable-trade-current https://stock.noler.com/us/stock/zyme/accounts-receivable https://stock.noler.com/us/stock/zyme/accrued-income-taxes-current https://stock.noler.com/us/stock/zyme/accumulated-depreciation https://stock.noler.com/us/stock/zyme/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/zyme/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/zyme/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/zyme/activist-13d-13g https://stock.noler.com/us/stock/zyme/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/zyme/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/zyme/amended-reports-10-k https://stock.noler.com/us/stock/zyme/amortization https://stock.noler.com/us/stock/zyme/amortization-of-financing-costs https://stock.noler.com/us/stock/zyme/analyst-ratings-buy https://stock.noler.com/us/stock/zyme/analyst-ratings-hold https://stock.noler.com/us/stock/zyme/analyst-ratings-no-rating https://stock.noler.com/us/stock/zyme/analyst-ratings-sell https://stock.noler.com/us/stock/zyme/aoci https://stock.noler.com/us/stock/zyme/assets-fair-value-disclosure https://stock.noler.com/us/stock/zyme/auditor https://stock.noler.com/us/stock/zyme/available-for-sale-debt-amortized-cost-excluding-accrued-interest-before-allowance-for-credit-loss https://stock.noler.com/us/stock/zyme/available-for-sale-debt-excluding-accrued-interest https://stock.noler.com/us/stock/zyme/available-for-sale-debt-excluding-accrued-interest-current https://stock.noler.com/us/stock/zyme/available-for-sale-debt-excluding-accrued-interest-noncurrent https://stock.noler.com/us/stock/zyme/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/zyme/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/zyme/available-for-sale-debt-unrealized-gain-loss https://stock.noler.com/us/stock/zyme/basic-shares https://stock.noler.com/us/stock/zyme/business https://stock.noler.com/us/stock/zyme/buybacks-share-repurchases https://stock.noler.com/us/stock/zyme/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/zyme/capital-expenditures https://stock.noler.com/us/stock/zyme/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/zyme/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/zyme/cash-and-equivalents https://stock.noler.com/us/stock/zyme/cash-and-restricted-cash https://stock.noler.com/us/stock/zyme/cash-flow-breakdown https://stock.noler.com/us/stock/zyme/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/zyme/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/zyme/clinical-trials https://stock.noler.com/us/stock/zyme/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/zyme/common-stock-value https://stock.noler.com/us/stock/zyme/company-guidance https://stock.noler.com/us/stock/zyme/company-profile https://stock.noler.com/us/stock/zyme/comprehensive-income https://stock.noler.com/us/stock/zyme/concentration-risk-credit-risk-financial-instrument-maximum-exposure https://stock.noler.com/us/stock/zyme/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/zyme/congressional-trades-stocks-including-adrs https://stock.noler.com/us/stock/zyme/contract-liability https://stock.noler.com/us/stock/zyme/contract-with-customer-asset-net https://stock.noler.com/us/stock/zyme/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/zyme/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/zyme/convertible-securities-retired https://stock.noler.com/us/stock/zyme/costs-and-expenses https://stock.noler.com/us/stock/zyme/cover-page-shares-outstanding https://stock.noler.com/us/stock/zyme/current-assets https://stock.noler.com/us/stock/zyme/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/zyme/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/zyme/current-income-tax-expense-benefit https://stock.noler.com/us/stock/zyme/current-liabilities https://stock.noler.com/us/stock/zyme/current-ratio https://stock.noler.com/us/stock/zyme/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/zyme/debt-and-equity-securities-unrealized-gain-loss https://stock.noler.com/us/stock/zyme/debt-equity-ratio https://stock.noler.com/us/stock/zyme/debt-securities-trading-and-equity-securities-fv-ni-cost https://stock.noler.com/us/stock/zyme/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/zyme/deferred-finance-costs-current-net https://stock.noler.com/us/stock/zyme/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/zyme/deferred-income-tax-assets-net https://stock.noler.com/us/stock/zyme/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/zyme/deferred-income-tax-liabilities https://stock.noler.com/us/stock/zyme/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/zyme/deferred-revenue-recognized https://stock.noler.com/us/stock/zyme/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/zyme/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/zyme/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/zyme/deferred-tax-assets-gross https://stock.noler.com/us/stock/zyme/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/zyme/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/zyme/deferred-tax-assets-net https://stock.noler.com/us/stock/zyme/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/zyme/deferred-tax-assets-other https://stock.noler.com/us/stock/zyme/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/zyme/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-contingencies https://stock.noler.com/us/stock/zyme/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/zyme/deferred-tax-liabilities https://stock.noler.com/us/stock/zyme/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/zyme/deferred-tax-liabilities-other https://stock.noler.com/us/stock/zyme/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/zyme/depreciation https://stock.noler.com/us/stock/zyme/derivative-fair-value-of-derivative-liability https://stock.noler.com/us/stock/zyme/derivative-liabilities https://stock.noler.com/us/stock/zyme/diluted-shares https://stock.noler.com/us/stock/zyme/dilutive-shares https://stock.noler.com/us/stock/zyme/dividend https://stock.noler.com/us/stock/zyme/dividend-safety https://stock.noler.com/us/stock/zyme/ebitda https://stock.noler.com/us/stock/zyme/ebitda-margin https://stock.noler.com/us/stock/zyme/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/zyme/effective-tax-rate https://stock.noler.com/us/stock/zyme/employee-count https://stock.noler.com/us/stock/zyme/employee-related-liabilities-current https://stock.noler.com/us/stock/zyme/eps https://stock.noler.com/us/stock/zyme/eps-basic https://stock.noler.com/us/stock/zyme/equity-securities-fv-ni-current-and-noncurrent https://stock.noler.com/us/stock/zyme/executive-pay-pvp https://stock.noler.com/us/stock/zyme/executive-salary-officers https://stock.noler.com/us/stock/zyme/expense-breakdown https://stock.noler.com/us/stock/zyme/finance-lease-liability https://stock.noler.com/us/stock/zyme/finance-lease-liability-current https://stock.noler.com/us/stock/zyme/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/zyme/finance-lease-principal-payments https://stock.noler.com/us/stock/zyme/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/zyme/financial-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/zyme/financing-cash-flow https://stock.noler.com/us/stock/zyme/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/zyme/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/zyme/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/zyme/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/zyme/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/zyme/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/zyme/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/zyme/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/zyme/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/zyme/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/zyme/foreign-pretax-income https://stock.noler.com/us/stock/zyme/form-144-stocks https://stock.noler.com/us/stock/zyme/form-n-port-stocks https://stock.noler.com/us/stock/zyme/general-and-administrative-expense https://stock.noler.com/us/stock/zyme/goodwill https://stock.noler.com/us/stock/zyme/goodwill-impairment-loss https://stock.noler.com/us/stock/zyme/graph https://stock.noler.com/us/stock/zyme/gross-margin https://stock.noler.com/us/stock/zyme/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/zyme/included-in-etf https://stock.noler.com/us/stock/zyme/income-tax https://stock.noler.com/us/stock/zyme/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/zyme/income-tax-paid-federal-after-refund-received https://stock.noler.com/us/stock/zyme/income-tax-paid-state-and-local-after-refund-received https://stock.noler.com/us/stock/zyme/income-taxes-paid https://stock.noler.com/us/stock/zyme/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/zyme/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/zyme/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/zyme/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/zyme/increase-decrease-in-deferred-income-taxes https://stock.noler.com/us/stock/zyme/increase-decrease-in-income-taxes https://stock.noler.com/us/stock/zyme/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/zyme/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/zyme/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/zyme/insider-transactions https://stock.noler.com/us/stock/zyme/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/zyme/investing-cash-flow https://stock.noler.com/us/stock/zyme/iran-activity-notices-irannotice https://stock.noler.com/us/stock/zyme/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/zyme/lease-cost https://stock.noler.com/us/stock/zyme/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/zyme/liabilities-other-than-longterm-debt-noncurrent https://stock.noler.com/us/stock/zyme/long-term-investments https://stock.noler.com/us/stock/zyme/market-cap https://stock.noler.com/us/stock/zyme/material-contracts https://stock.noler.com/us/stock/zyme/net-change-in-cash https://stock.noler.com/us/stock/zyme/net-income https://stock.noler.com/us/stock/zyme/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/zyme/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/zyme/net-margin https://stock.noler.com/us/stock/zyme/news https://stock.noler.com/us/stock/zyme/number-of-operating-segments https://stock.noler.com/us/stock/zyme/number-of-reportable-segments https://stock.noler.com/us/stock/zyme/number-of-reporting-units https://stock.noler.com/us/stock/zyme/oci-available-for-sale-tax https://stock.noler.com/us/stock/zyme/oci-net-of-tax https://stock.noler.com/us/stock/zyme/oci-net-of-tax-2 https://stock.noler.com/us/stock/zyme/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/zyme/operating-cash-flow https://stock.noler.com/us/stock/zyme/operating-income https://stock.noler.com/us/stock/zyme/operating-lease-assets https://stock.noler.com/us/stock/zyme/operating-lease-cost https://stock.noler.com/us/stock/zyme/operating-lease-expense https://stock.noler.com/us/stock/zyme/operating-lease-impairment-loss https://stock.noler.com/us/stock/zyme/operating-lease-liability https://stock.noler.com/us/stock/zyme/operating-lease-liability-current https://stock.noler.com/us/stock/zyme/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/zyme/operating-lease-payments https://stock.noler.com/us/stock/zyme/operating-lease-payments-due https://stock.noler.com/us/stock/zyme/operating-lease-payments-due-after-rolling-year-five https://stock.noler.com/us/stock/zyme/operating-lease-payments-due-in-rolling-year-five https://stock.noler.com/us/stock/zyme/operating-lease-payments-due-in-rolling-year-four https://stock.noler.com/us/stock/zyme/operating-lease-payments-due-in-rolling-year-three https://stock.noler.com/us/stock/zyme/operating-lease-payments-due-in-rolling-year-two https://stock.noler.com/us/stock/zyme/operating-lease-payments-due-next-rolling-twelve-months https://stock.noler.com/us/stock/zyme/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/zyme/operating-loss-carryforwards https://stock.noler.com/us/stock/zyme/operating-margin https://stock.noler.com/us/stock/zyme/options-activity https://stock.noler.com/us/stock/zyme/other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/zyme/other-accrued-liabilities-noncurrent https://stock.noler.com/us/stock/zyme/other-current-liabilities https://stock.noler.com/us/stock/zyme/other-income https://stock.noler.com/us/stock/zyme/other-noncurrent-liabilities https://stock.noler.com/us/stock/zyme/other-nonoperating-income-expense https://stock.noler.com/us/stock/zyme/other-operating-income-expense-net https://stock.noler.com/us/stock/zyme/outstanding-bonds https://stock.noler.com/us/stock/zyme/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/zyme/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/zyme/patents-active https://stock.noler.com/us/stock/zyme/payments-for-proceeds-from-investments https://stock.noler.com/us/stock/zyme/payments-for-proceeds-from-short-term-investments https://stock.noler.com/us/stock/zyme/payments-of-financing-costs https://stock.noler.com/us/stock/zyme/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/zyme/payments-to-acquire-longterm-investments https://stock.noler.com/us/stock/zyme/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/zyme/pb-ratio https://stock.noler.com/us/stock/zyme/pe-ratio https://stock.noler.com/us/stock/zyme/pre-tax-margin https://stock.noler.com/us/stock/zyme/preferred-shares-facts https://stock.noler.com/us/stock/zyme/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/zyme/preferred-stock-shares-authorized https://stock.noler.com/us/stock/zyme/preferred-stock-shares-issued https://stock.noler.com/us/stock/zyme/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/zyme/preferred-stock-value https://stock.noler.com/us/stock/zyme/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/zyme/prepaid-expense-and-other-assets-noncurrent https://stock.noler.com/us/stock/zyme/prepaid-expense-noncurrent https://stock.noler.com/us/stock/zyme/pretax-income https://stock.noler.com/us/stock/zyme/pretax-income-domestic https://stock.noler.com/us/stock/zyme/previous-etf-holding-it https://stock.noler.com/us/stock/zyme/price-fcf-ratio https://stock.noler.com/us/stock/zyme/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/zyme/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/zyme/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/zyme/proceeds-from-stock-issued https://stock.noler.com/us/stock/zyme/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/zyme/profit-breakdown https://stock.noler.com/us/stock/zyme/profit-loss https://stock.noler.com/us/stock/zyme/property-plant-and-equipment-gross https://stock.noler.com/us/stock/zyme/property-plant-equipment https://stock.noler.com/us/stock/zyme/ps-ratio https://stock.noler.com/us/stock/zyme/public-float https://stock.noler.com/us/stock/zyme/quick-ratio https://stock.noler.com/us/stock/zyme/research-and-development https://stock.noler.com/us/stock/zyme/research-and-development-asset-acquired-other-than-through-acquisition-written-off https://stock.noler.com/us/stock/zyme/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/zyme/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/zyme/restructuring-charges https://stock.noler.com/us/stock/zyme/restructuring-reserve https://stock.noler.com/us/stock/zyme/retained-earnings https://stock.noler.com/us/stock/zyme/return-on-tangible-equity https://stock.noler.com/us/stock/zyme/revenue https://stock.noler.com/us/stock/zyme/revenue-breakdown https://stock.noler.com/us/stock/zyme/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/zyme/roa https://stock.noler.com/us/stock/zyme/roe https://stock.noler.com/us/stock/zyme/roi https://stock.noler.com/us/stock/zyme/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/zyme/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/zyme/sales-and-excise-tax-payable-current https://stock.noler.com/us/stock/zyme/scorecard https://stock.noler.com/us/stock/zyme/sec-comment-letters-upload https://stock.noler.com/us/stock/zyme/sec-enforcement-actions https://stock.noler.com/us/stock/zyme/sec-filings-10-q https://stock.noler.com/us/stock/zyme/sec-filings-25-nse https://stock.noler.com/us/stock/zyme/sec-filings-8-k https://stock.noler.com/us/stock/zyme/sec-filings-px14a6g https://stock.noler.com/us/stock/zyme/sec-filings-s-4 https://stock.noler.com/us/stock/zyme/secondary-offerings https://stock.noler.com/us/stock/zyme/share-repurchase-program-excise-tax https://stock.noler.com/us/stock/zyme/shareholders-equity https://stock.noler.com/us/stock/zyme/shares-authorized https://stock.noler.com/us/stock/zyme/shares-issued https://stock.noler.com/us/stock/zyme/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/zyme/shares-outstanding https://stock.noler.com/us/stock/zyme/short-sale-volume https://stock.noler.com/us/stock/zyme/short-term-investments https://stock.noler.com/us/stock/zyme/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/zyme/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/zyme/stock-award-fair-value-assumptions-weighted-average-volatility-rate https://stock.noler.com/us/stock/zyme/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/zyme/stock-award-percentage-of-outstanding-stock-maximum https://stock.noler.com/us/stock/zyme/stock-based-compensation https://stock.noler.com/us/stock/zyme/stock-issued-new-shares-sold https://stock.noler.com/us/stock/zyme/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/zyme/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/zyme/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/zyme/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/zyme/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/zyme/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/zyme/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/zyme/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/zyme/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/zyme/stock-options-nonvested-options-forfeited-grant-date-fair-value https://stock.noler.com/us/stock/zyme/stock-options-nonvested-options-forfeited-number-of-shares https://stock.noler.com/us/stock/zyme/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/zyme/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/zyme/stock-splits https://stock.noler.com/us/stock/zyme/subsidiaries https://stock.noler.com/us/stock/zyme/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/zyme/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/zyme/tax-rate-reconciliation-cross-border-other-amount https://stock.noler.com/us/stock/zyme/tax-rate-reconciliation-cross-border-other-percent https://stock.noler.com/us/stock/zyme/tax-rate-reconciliation-fdii-amount https://stock.noler.com/us/stock/zyme/tax-rate-reconciliation-fdii-percent https://stock.noler.com/us/stock/zyme/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/zyme/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/zyme/tax-rate-reconciliation-tax-contingencies https://stock.noler.com/us/stock/zyme/tax-rate-reconciliation-tax-settlements-state-and-local https://stock.noler.com/us/stock/zyme/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/zyme/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/zyme/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/zyme/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/zyme/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/zyme/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/zyme/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/zyme/tax-reconciliation-tax-contingencies https://stock.noler.com/us/stock/zyme/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/zyme/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/zyme/total-assets https://stock.noler.com/us/stock/zyme/total-contract-liability https://stock.noler.com/us/stock/zyme/total-liabilities https://stock.noler.com/us/stock/zyme/total-liabilities-and-equity https://stock.noler.com/us/stock/zyme/trading-securities https://stock.noler.com/us/stock/zyme/treasury-stock-retired-cost-method-amount https://stock.noler.com/us/stock/zyme/unrealized-gain-loss-on-investments https://stock.noler.com/us/stock/zyme/unrecognized-tax-benefits https://stock.noler.com/us/stock/zyme/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/zyme/utb-decrease-from-settlements https://stock.noler.com/us/stock/zyme/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/zyme/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/zyme/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/zyme/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/zyme/variable-lease-cost https://stock.noler.com/us/stock/zyme/variable-lease-payment